Aethlon Medical Inc AEMD

NAS: AEMD | ISIN: US00808Y3071   31/05/2024
0,437 USD (+9,25%)
(+9,25%)   31/05/2024

15 mei 2024 · Aethlon Medical Announces Pricing of $4.7 Million Public Offering · Persbericht

10 mei 2024 · Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma · Persbericht

21 februari 2024 · Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices · Persbericht

14 februari 2024 · Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update · Persbericht

7 februari 2024 · Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 · Persbericht

6 november 2023 · Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 · Persbericht

10 oktober 2023 · Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology · Persbericht

4 oktober 2023 · Aethlon Announces Reverse Stock Split · Persbericht

30 augustus 2023 · Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference · Persbericht

10 augustus 2023 · Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update · Persbericht

3 augustus 2023 · Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 · Persbericht

24 juli 2023 · Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant · Persbericht

6 juli 2023 · Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors · Persbericht

28 juni 2023 · Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update · Persbericht

22 juni 2023 · Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023 · Persbericht

21 juni 2023 · Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation · Persbericht

14 juni 2023 · Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest · Persbericht

1 juni 2023 · Aethlon Medical to Present at the 13th Annual LD Micro Invitational · Persbericht

22 mei 2023 · Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India · Persbericht

13 februari 2023 · Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update · Persbericht

Mijn selecties